The compound effectively suppressed the proliferation of both K-Ras mutant (MiaPaca2, Panc1, and Capan2) and wild-type K-Ras (BxPC3) pancreatic cancer cells at remarkably low concentrations. This evidence concerns the gene KRAS and familial pancreatic carcinoma.